Development Level

Tbio 5 | 11,445
Tchem 4 | 1,598
Tclin 1 | 613

IMPC Phenotype

preweaning lethality, complete... 2 | 979
increased circulating sodium l... 1 | 71
preweaning lethality, incomple... 1 | 499

Disease

Cancer 8 | 2,499
ovarian cancer 7 | 8,520
Carcinoma 6 | 11,493
lung cancer 6 | 4,740
osteosarcoma 6 | 7,950
group 3 medulloblastoma 5 | 4,104
tuberculosis 5 | 2,010
atypical teratoid / rhabdoid tumor 4 | 5,112
malignant mesothelioma 4 | 3,232
psoriasis 4 | 6,694
Breast cancer 3 | 3,578
Kidney cancer 3 | 2,613
Prostatic Neoplasms 3 | 495
Schizophrenia 3 | 1,160
Stomach Neoplasms 3 | 300
glioblastoma 3 | 5,792
juvenile dermatomyositis 3 | 1,187
medulloblastoma, large-cell 3 | 6,241
pancreatic cancer 3 | 2,398
Alkaline phosphatase serum increased 2 | 29
Alzheimer's disease 2 | 658
Astrocytoma, Pilocytic 2 | 3,081
Ataxia telangiectasia 2 | 34
Autosomal recessive predisposition 2 | 1,442
Blastic phase chronic myeloid leukemia 2 | 58
Breast Neoplasms 2 | 445
Chronic Myelocytic Leukemia Accelerated Phase 2 | 59
Chronic phase chronic myeloid leukemia 2 | 45
Cognitive delay 2 | 608
Gastrointestinal stromal tumor 2 | 62
Global developmental delay 2 | 608
Intellectual disability 2 | 1,016
Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 | 20
Liver neoplasms 2 | 130
Lung Neoplasms 2 | 232
Mammary Neoplasms 2 | 425
Mental and motor retardation 2 | 608
Myeloid Leukemia, Chronic 2 | 23
Pancreatic Neoplasm 2 | 85
Parkinson's disease 2 | 392
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 2 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 2 | 47
Vascular disease 2 | 319
adrenocortical carcinoma 2 | 1,428
adult high grade glioma 2 | 3,801
breast carcinoma 2 | 1,638
ependymoma 2 | 4,679
primary pancreatic ductal adenocarcinoma 2 | 1,109
Adenocarcinoma 1 | 122
Carcinogenesis 1 | 8
Chloracne 1 | 32
Collapse of vertebra 1 | 14
Compression fracture of vertebral column 1 | 14
Edema 1 | 81
Encephalopathy, progressive 1 | 6
Glioma 1 | 74
Hereditary Breast and Ovarian Cancer Syndrome 1 | 14
Hyperphosphatemia (disorder) 1 | 17
Increased risk of pancreatic cancer 1 | 9
Juvenile osteoporosis 1 | 4
Li-Fraumeni syndrome 1 | 13
Li-Fraumeni syndrome 2 1 | 2
Lytic lesion 1 | 32
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1 1 | 16
Malignant neoplasm of pancreas 1 | 9
Malignant neoplasm of prostate 1 | 11
Malignant neoplasm of skin 1 | 15
Malignant tumor of prostate 1 | 26
Marijuana Abuse 1 | 31
Meningioma 1 | 41
Microcephalic osteodysplastic primordial dwarfism type II 1 | 13
Myocardial Reperfusion Injury 1 | 37
Neoplasms, Experimental 1 | 40
Nervous System Neoplasms 1 | 8
OSTEOGENESIS IMPERFECTA, TYPE XV 1 | 1
Osteogenesis Imperfecta, Type 15 1 | 1
Osteogenesis imperfecta 1 | 34
Osteogenesis imperfecta type III (disorder) 1 | 11
Osteogenesis imperfecta type IV (disorder) 1 | 10
Osteogenic Sarcoma 1 | 6
Osteoporosis, Juvenile 1 | 4
Pain 1 | 103
Pancreatic Neuroendocrine Tumor 1 | 45
Peripheral Neuropathy 1 | 134
Platyspondyly 1 | 56
Precancerous Conditions 1 | 80
Progressive brain disease 1 | 6
Renal Cell Carcinoma 1 | 214
Retinal Neoplasms 1 | 3
Retinoblastoma 1 | 19
SERUM PHOSPHATE ELEVATED 1 | 14
Sarcoma 1 | 62
Skin Neoplasms 1 | 69
Stomach Carcinoma 1 | 11
Stomach cancer 1 | 30
Tumors of Adrenal Cortex 1 | 3
axial spondyloarthropathy 1 | 28
osteogenesis imperfecta type 3 1 | 11
osteogenesis imperfecta type 4 1 | 10
osteoporosis-pseudoglioma syndrome 1 | 9

Tissue

Blood and immune system 10 | 16,909
Digestive Tract 10 | 17,369
Endocrine System 10 | 18,159
Female tissues 10 | 17,400
Liver and Pancreas 10 | 16,750
Nervous System 10 | 16,725
Respiratory system 10 | 16,393
Urinary Tract 10 | 16,678
Cardiovascular System 9 | 15,192
Male tissues 9 | 17,142
Skin and soft tissues 9 | 17,230

Target Family

Non-IDG 6 | 12,091
Kinase 3 | 634
Enzyme 1 | 4,145

GO Process

signal transduction in respons... 10 | 10
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Post-GPI attachment to proteins factor 2 PGAP2 Tbio Non-IDG -1.08727 12.0 64
Caspase-9 CASP9 Tchem Enzyme -3.44725 2332.0 1313
Serine/threonine-protein kinase Chk2 CHEK2 Tchem Kinase -3.00304 978.7 1374
Centrosomal protein of 63 kDa CEP63 Tbio Non-IDG -1.75874 45.6 110
Tyrosine-protein kinase ABL1 ABL1 Tclin Kinase -3.51854 3418.5 1661
Growth factor receptor-bound protein 2 GRB2 Tchem Non-IDG -3.02404 981.4 501
Growth arrest and DNA damage-inducible protein GADD45 alpha GADD45A Tbio Non-IDG -2.61061 373.3 249
Proto-oncogene Wnt-1 WNT1 Tbio Non-IDG -2.76391 516.8 355
BH3-interacting domain death agonist BID Tbio Non-IDG -1.85313 58.9 981
Mitogen-activated protein kinase 14 MAPK14 Tchem Kinase -3.36007 2240.8 1574